Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

References

• World Health Organization (WHO). Pertussis vaccines: WHO position paper, August 2015. Recommendations. Vaccine. 2016; 34(12):1423-5; http://dx.doi.org/10.1016/j.vaccine.2015.10.136. Epub 2015 Nov 10.
   Google Scholar
• Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2014; (9):CD001478
   PubMed Web of Science ®Google Scholar
• Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions? Expert Rev Vaccines 2012; 11:1331-46; PMID:23249233; http://dx.doi.org/10.1586/erv.12.118
   PubMed Web of Science ®Google Scholar
• Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn J, Cousens S, Mathers C, Black RE. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015; 385:430-40; PMID:25280870; http://dx.doi.org/10.1016/S0140-6736(14)61698-6
   PubMed Web of Science ®Google Scholar
• Hiappini E, Stival A, Galli L, de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis. 2013;13:151.
   Google Scholar
• Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014; 133:e513-9; PMID:24515514; http://dx.doi.org/10.1542/peds.2013-3181
   PubMed Web of Science ®Google Scholar
• Acosta AM, Debolt C, Tasslimi A, Lewis M, Stewart LK. Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic. Pediatrics 2015; 135:981-9; PMID:25941309; http://dx.doi.org/10.1542/peds.2014-3358
   PubMed Web of Science ®Google Scholar
• Ibsen PH. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 1996; 14:359-68; PMID:8735545; http://dx.doi.org/10.1016/0264-410X(95)00230-X
   PubMed Web of Science ®Google Scholar
• Sutherland JN, Chang C, Yoder SM, Rock MT, Maynard JA. Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization. Clin Vaccine Immunol 2011; 18:954-62; PMID:21508166; http://dx.doi.org/10.1128/CVI.00561-10
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Urbani F, Sala A, Lande R, Cassone A. Vaccine- and Antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65(6):2168-74; PMID:9169747
   PubMed Web of Science ®Google Scholar
• Higgs R, Higgins SC, Ross PJ, Mills KHG. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012; 5:485-500; PMID:22718262
   PubMed Web of Science ®Google Scholar
• Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiology and infection 2014; 142:685-94; PMID:23406868; http://dx.doi.org/10.1017/S0950268813000071
   PubMed Web of Science ®Google Scholar
• Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 2014; 13:1135-46; PMID:24953157; http://dx.doi.org/10.1586/14760584.2014.932254
   PubMed Web of Science ®Google Scholar
• Plotkin S. The pertussis problem. Clin Infect Dis 2014; 58:830-3; PMID:24363332; http://dx.doi.org/10.1093/cid/cit934
   PubMed Web of Science ®Google Scholar
• Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334:341-8; PMID:8538704; http://dx.doi.org/10.1056/NEJM199602083340601
   PubMed Web of Science ®Google Scholar
• Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001; 108:E81; PMID:11694665; http://dx.doi.org/10.1542/peds.108.5.e81
   PubMed Web of Science ®Google Scholar
• Di Tommaso A, De Magistris MT, Bugnoli M, Marsili I, Rappuoli R, Abrignani S. Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing. Infect Immun 1994; 62:1830-4; PMID:7513307
   PubMed Web of Science ®Google Scholar
• Buasri W, Impoolsup A, Boonchird C, Luengchaichawange A, Prompiboon P, Petre J, Panbangred W. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange. BMC Microbiol 2012; 12:61; PMID:22524455; http://dx.doi.org/10.1186/1471-2180-12-61
   PubMed Web of Science ®Google Scholar
• Seubert A, D'Oro U, Scarselli M, Pizza M. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines. Expert Rev Vaccines 2014; 13:1191-204; PMID:25183193; http://dx.doi.org/10.1586/14760584.2014.942641
   PubMed Web of Science ®Google Scholar
• Meade BD, Lynn F, Reed GF, Mink CM, Romani T, Deforest A, Deloria MA. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics 1995; 96:595-600; PMID:7659484
   PubMed Web of Science ®Google Scholar
• Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-34
   PubMedGoogle Scholar
• Watanabe M, Nagai M. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect Immun 2001; 69:6981-6; http://dx.doi.org/10.1128/IAI.69.11.6981-6986.2001
   PubMed Web of Science ®Google Scholar
• Xing D, Markey K, Newland P, Rigsby P, Hockley J, He Q. EUVAC NET collaborative study: Evaluation and standardisation of serology for diagnosis of pertussis. J Immunol Methods 2011; 372:137-45
   PubMed Web of Science ®Google Scholar
• Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, et al. Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays. Clin Vaccine Immunol 2012; 19(1):64-72; http://dx.doi.org/10.1128/CVI.05460-11
   PubMed Web of Science ®Google Scholar
• Recommendations to assure the quality, safety and efficacy of acellular pertussis vaccines. Replacement of Annex 2 of WHO Technical Report Series, No. 878. In: WHO Expert Committee on Biological Standardization. Sixty-second report. Geneva, World Health Organization, 2013 (WHO Technical Report Series, No. 927), Annex 4.
   Google Scholar
• Taranger J, Trollfors B, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000; 181:1010-3; PMID:10720524; http://dx.doi.org/10.1086/315318
   PubMed Web of Science ®Google Scholar
• Gorringe AR, Vaughan TE. Bordetella pertussis fimbriae (Fim): relevance for vaccines. Expert Rev Vaccines 2014; 13:1205-14; PMID:25102891; http://dx.doi.org/10.1586/14760584.2014.930667
   PubMed Web of Science ®Google Scholar
• Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J. How to make sense of pertussis immunogenicity data. Clin Infect Dis 2001; 33 Suppl 4:S288-91; PMID:11709761; http://dx.doi.org/10.1086/322564
   PubMedGoogle Scholar
• Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16:1901-6; PMID:9796041; http://dx.doi.org/10.1016/S0264-410X(98)00226-6
   PubMed Web of Science ®Google Scholar
• Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults–a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013; 31(45):5178-91; http://dx.doi.org/10.1016/j.vaccine.2013.08.034
   PubMed Web of Science ®Google Scholar
• Sanofi Pasteur 306 - Adacel®. Full Prescribing Information. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM142764.pdf
   Google Scholar